Sunshine Biopharma Inc. (SBFM)
NASDAQ: SBFM
· Real-Time Price · USD
1.51
0.00 (0.00%)
At close: Aug 15, 2025, 2:59 PM
Sunshine Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.16M | -1.2M | -494.3K | -1.28M | -1.25M | -651.48K | -902.11K | -1.7M | -23.51M | -1.46M | -538.87K | -1.24M | 667.12K | -4.04M | -2.88M | -6.19M |
Depreciation & Amortization | 65.4K | 64.63K | 50.87K | 42.62K | 42.35K | 37.2K | 34.88K | 34.71K | 18.98K | 789.00 | 2.29K | 3.11K | 3.18K | 3.18K | 3.19K | 3.18K |
Stock-Based Compensation | n/a | n/a | n/a | 12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 918K |
Other Working Capital | 2M | -1.5M | -3.46M | -612.8K | 913.88K | 41.03K | -1.22M | 172.7K | 322.92K | 21.17K | -9.93K | -57.29K | -33.33K | 9.56K | 1.51K | 19.37K |
Other Non-Cash Items | -2.25M | 2.55M | 780.6K | 1.44M | 377.00 | -374 | 1.76M | n/a | 18.33M | 65.00 | -10.88K | 9.00 | -903.7K | 3.5M | 2.33M | 5.78M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.63K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 937.57K | -2.78M | -4.13M | -1.96M | -1.48M | 157.37K | -2.91M | -182.39K | 2.92M | 332.43K | -26.34K | -71.09K | -78.72K | -60.67K | -69.38K | 99.97K |
Operating Cash Flow | -3.41M | -1.36M | -4.58M | -3.19M | -2.69M | -457.29K | -3.78M | -1.85M | -2.25M | -1.12M | -573.8K | -1.3M | -312.11K | -600.81K | -618.85K | -297.36K |
Capital Expenditures | -439.3K | -517K | -572.22K | -699.8K | -303.68K | -11.79K | -294.23K | -178.4K | -305K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | 30.01K | 31.07K | 34.45K | 30.65K | 67.69K | -1.14K | -14.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -87.4K | -61.36K | n/a | -605.8K | -651.59K | 28.49K | -32.93K | 33.23K | -1.14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -531.53K | -578.37K | -542.21K | -668.74K | -269.23K | 18.86K | -259.48K | -146.3K | -14.62M | -41.56M | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | 435.79K | -29.66K | n/a | -29.61K | n/a | -29.25K | -32.39K | -31.48K | -2.1M | n/a | n/a | -1.9M | -23.66K | -124.31K | -279.35K | -48K |
Common Stock Repurchased | n/a | n/a | n/a | -3.14M | 541.14K | -34.32K | n/a | -506.82K | -99K | n/a | n/a | -99K | -3.32M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.62M | 1.9M | -28.58K | 45K | -30.52K | n/a | 1.16K | n/a | 13.19M | n/a | n/a | 99K | n/a | n/a | 61.5K | n/a |
Financial Cash Flow | 2.05M | 1.87M | -28.58K | 5.4M | -30.52K | -63.57K | 4.06M | -538.3K | -2.1M | 41.56M | 29.12M | 12.44M | -23.66K | 1.28M | 550.65K | 1.1M |
Net Cash Flow | -2.52M | 698.91K | -5.93M | 1.14M | -2.55M | -883.35K | 435.27K | -2.53M | -18.73M | -1.17M | 28.55M | 11.13M | -341.44K | 651.51K | -61.5K | 806.71K |
Free Cash Flow | -3.85M | -1.88M | -5.15M | -3.88M | -2.99M | -469.08K | -4.07M | -2.03M | -2.55M | -1.12M | -573.8K | -1.3M | -312.11K | -600.81K | -618.85K | -297.36K |